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The FANCJ DNA helicase is mutated in hereditary breast and ovarian cancer as well as the
progressive bone marrow failure disorder Fanconi anemia (FA). FANCJ is linked to cancer
suppression and DNA double strand break repair through its direct interaction with the
hereditary breast cancer associated gene product, BRCA1. FANCJ also operates in the
FA pathway of interstrand cross-link repair and contributes to homologous recombination.
FANCJ collaborateswith a number ofDNAmetabolizing proteins implicated inDNAdamage
detection and repair, and plays an important role in cell cycle checkpoint control. In addition
to its role in the classical FA pathway, FANCJ is believed to have other functions that
are centered on alleviating replication stress. FANCJ resolves G-quadruplex (G4) DNA
structures that are known to affect cellular replication and transcription, and potentially
play a role in the preservation and functionality of chromosomal structures such as
telomeres. Recent studies suggest that FANCJ helps to maintain chromatin structure
and preserve epigenetic stability by facilitating smooth progression of the replication fork
when it encounters DNA damage or an alternate DNA structure such as a G4. Ongoing
studies suggest a prominent but still not well-understood role of FANCJ in transcriptional
regulation, chromosomal structure and function, and DNA damage repair to maintain
genomic stability. This review will synthesize our current understanding of the molecular
and cellular functions of FANCJ that are critical for chromosomal integrity.
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DISCOVERY OF BACH1/BRIP1/FANCJ AND ITS EMERGENCE
AS A PROMINENT PLAYER IN HUMAN GENETIC DISEASE
AND TUMOR SUPPRESSION
FANCJ (originally named BRCA1 interacting C-terminal heli-
case (BACH1) or BRCA1 interacting helicase (BRIP1) was ﬁrst
discovered by its physical interaction with BRCA1, a known
tumor suppressor and mediator of double strand break (DSB)
repair (Cantor et al., 2001). Consistent with FANCJ’s association
with BRCA1, FANCJ-deﬁcient cells are sensitive to DNA cross-
linking agents (Bridge et al., 2005; Levitus et al., 2005; Litman
et al., 2005) and mildly sensitive to ionizing radiation (IR; Peng
et al., 2006), and display a defect in homologous recombination
(HR) repair of DSBs (Litman et al., 2005). The ﬁrst clinical evi-
dence for the importance of FANCJ was the identiﬁcation of
germ line sequence changes in FANCJ that were associated with
early breast cancer in two individuals that displayed normal geno-
types for BRCA1 and BRCA2 (Cantor et al., 2001). Subsequent
studies solidiﬁed the causal relationship of FANCJ mutations
as low penetrance breast and ovarian cancer alleles (Seal et al.,
2006; Rafnar et al., 2011; for review, see Cantor and Guillemette,
2011).
In accord with its role as a tumor suppressor, FANCJ was
identiﬁed as the gene mutated in the J complementation group
of Fanconi anemia (FA), a rare disorder characterized by pro-
gressive bone marrow failure, skeletal abnormalities, and cancer
(Levitus et al., 2005; Levran et al., 2005; Litman et al., 2005).
Currently, there are 16 FA complementation groups. The corre-
sponding genes encode proteins implicated in a complex pathway
of interstrand cross-link (ICL) repair that corrects damage when
the two complementary strands of the DNA double helix become
covalently linked, a type of lesion that blocks cellular DNA repli-
cation and transcription (Figure 1). The reader is referred to
several recently published excellent reviews on the functions of
the FA gene products and the overall workings of the FA pathway
and its importance in chromosomal stability (Kee and D’Andrea,
2012; Kottemann and Smogorzewska, 2013; Walden and Deans,
2014). One notable ﬁnding is that FANCJ is not required for
DNA damage induced FANCD2 monoubiquitination, suggest-
ing that the helicase functions downstream of this key activation
step of the FA pathway (Litman et al., 2005). FANCJ likely oper-
ates with other downstream BRCA-FA proteins, such as BRCA1,
and related factors also classiﬁed as tumor suppressors to facili-
tate recombinational repair (potentially following unhooking of
the processed cross-link; Figure 1). In addition, it is believed that
FANCJ functions in a broader role to suppress replication stress
(see subsequent sections).
The FANCJ gene encodes a protein of 1,249 amino acids
with a conserved ATPase helicase core domain comprised of
eight motifs [0 (Q), I, Ia, II, III, IV, V, VI] found in DEAH
superfamily two helicases (Figure 2). A signature motif in this
FANCJ family of DNA helicases is an Iron–Sulfur (Fe–S) cluster,
characterized by four conserved cysteine residues, residing within
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FIGURE 1 | Fanconi anemia (FA) proteins implicated in interstrand
cross-link (ICL) repair. Cartoon schematic of the FA proteins implicated in
the ICL repair pathway. The integrity of the core complex is required for
FANCD2/FANCI monoubiquitination, a key activation step of the FA
pathway. ERCC1-XPF is the nuclease implicated in ICL processing. FANCJ
and certain other FA proteins are not required for FANCD2/FANCI
monoubiquitination, and are therefore implicated in downstream events of
the FA pathway, such as homologous recombination (HR) repair of the
processed ICL.
the helicase core domain (Cantor et al., 2004; Rudolf et al., 2006).
Members of the Fe–S helicase cluster family function in preserv-
ing the genome, such as XPD and RTEL helicases (Wu et al.,
2009). Recently solved crystal structures and biochemical stud-
ies of thermophilic species of XPD suggest that the Fe–S cluster
functions with an Arch domain that is proposed to be a wedge
propelling strand separation. Moreover, two conserved RecA-
like domains mediate ATP binding, protein–DNA interactions,
and helicase translocation mediated by ATP-induced confor-
mational changes (Rudolf et al., 2006; Fan et al., 2008; Wolski
et al., 2008; Kuper et al., 2011). Studies on Fe–S cluster heli-
cases XPD (Mui et al., 2011; Sontz et al., 2012) and DinG (Ren
et al., 2009), as well as other DNA processing enzymes (Grodick
et al., 2014), have implicated the Fe–S cluster as a redox sen-
sor that facilitates DNA damage detection; however, a formal
role of the FANCJ Fe–S cluster in this capacity has not been
determined.
CATALYTIC ACTIVITIES AND DNA SUBSTRATE SPECIFICITY
OF FANCJ HELICASE
Biochemical characterization of the puriﬁed recombinant FANCJ
protein using a classic DNA directionality substrate (Cantor et al.,
2004) or oligonucleotide-based partial duplex substrates with
single-stranded DNA overhangs of deﬁned polarity (Gupta et al.,
2005) determined the 5′–3′ directionality of FANCJ as an ATP-
dependent DNA helicase. Biophysical analyses of FANCJ assembly
state suggest that the helicase exists in an equilibrium, as a
monomer, and dimer in solution. Furthermore, biochemical stud-
ies showed that the dimeric form of FANCJ displays maximal
catalytic activity as anATPase andDNAhelicase on relatively short
forked duplex substrates of 20 base pairs (bp; Wu et al., 2012).
FANCJ is limited in its processivity; therefore, it poorly unwinds
substrates with duplexes of ∼50 bp or greater. However, on both
shorter and longer duplexes its helicase activity is markedly stim-
ulated by the single-stranded DNA binding protein replication
protein A (RPA; Gupta et al., 2007).
The DNA substrate preference of FANCJ has been studied in
some detail (Figure 3). A 5′ tail of 15 nucleotides (nt) is required
and 35 nt is optimal for FANCJ to catalyze appreciable unwinding
of the simple 5′ tailed duplex (Gupta et al., 2005). FANCJ prefer-
entially binds and unwinds forked duplex DNA substrates (Gupta
et al., 2005), and is also active on a 5′ ﬂap (but not 3′ ﬂap) sub-
strate (Figure 3), consistent with its translocation directionality.
Backbone continuity in the pre-existing 5′ single-stranded DNA
tail, but not the 3′ single-stranded tail, of the forked duplex sub-
strate within six nt of the single-stranded DNA-double stranded
DNA junction is required for FANCJ to initiate unwinding of
the adjacent duplex. However, disruption of the sugar phosphate
backbone by a polyglycol modiﬁcation in either the translocat-
ing or non-translocating strand within the duplex region inhibits
FANCJ helicase activity (Gupta et al., 2006). This ﬁnding demon-
strates that FANCJ senses both strands during the elongation
phase of the unwinding reaction. Inhibition of FANCJ helicase
by the polyglycol modiﬁcation in either strand of the duplex sub-
strate can be overcome by increasing the 5′ single-stranded DNA
loading tail of the substrate (Gupta et al., 2006), suggesting that
loading of multiple FANCJ molecules under multi-turnover con-
ditions drives forward theDNAunwinding reaction evenwhen the
helicase encounters a formidable obstacle to progression. Interest-
ingly, FANCJ helicase activity is not inhibited by the presence of
abasic sites in either the translocating or non-translocating strands
within the duplex region of the forkedDNA substrate (Gupta et al.,
2006), suggesting that FANCJ’s electrostatic interactions with the
sugar phosphate backbone dominate over base-stacking interac-
tions. FANCJ helicase activity is also inhibited in a translocating
strand speciﬁc manner by an alkyl phosphotriester lesion that
introduces a hydrophobic group into the nucleic acid backbone
and neutralizes the negatively charged phosphodiester moiety
(Suhasini et al., 2012). Presumably, the physical attributes of the
alkyltriester damage or its effect on double helical rigidity dif-
ferentially affect FANCJ unwinding compared to the polyglycol
linkage, which inhibited irrespective of the strand. A number
of chemical genotoxins cause the formation of phosphotriester
adducts which can persist for a long time in genomic DNA (Jones
et al., 2010). These lesions and other DNA adducts may exert their
mutagenic and carcinogenic effects by inhibiting DNA metabo-
lizing enzymes, including helicases such as FANCJ (Suhasini and
Brosh, 2010).
To assess the possibility that FANCJ has a catalytic role in pro-
cessing an ICL intermediate in a DSB repair pathway, we assessed
its activity on a three-stranded displacement loop (D-loop) DNA
substrate that represents a key early intermediate of HR repair
(Gupta et al., 2005). Following unhooking of an ICL, a D-loop
arises after RAD51-mediated strand invasion and base-pairing
of a single-stranded DNA overhang formed at a resected DSB.
Notably, FANCJ unwinds a D-loop without a 5′ single-stranded
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FIGURE 2 | FANCJ and its catalytic helicase domain, characterized site-directed mutations, sites of post-translational modifications, and protein
interactions. See text for details.
DNA tail suggesting that the DNA junctions in the D-loop sub-
strate enable FANCJ to overcome its usually strict requirement for
loading on a 5′ single-stranded DNA tail to initiate unwinding
(Figure 3). However, FANCJ fails to unwind a four-stranded Hol-
liday Junction structure, another key intermediate of HR repair
that can lead to cross-over or non-crossover recombinant prod-
ucts (Gupta et al., 2005). Thus, FANCJ may be exquisitely tailored
to act upon D-loop intermediates to suppress HR or homeolo-
gous recombination. Alternatively, FANCJ may act upon D-loops
to enable synthesis-dependent strand annealing, a pathway of
DSB repair distinct from the classic Holliday Junction resolution
pathway.
In addition to unwinding conventional duplex DNA substrates,
FANCJ resolves alternate DNA structures including DNA triplexes
(Sommers et al., 2009) or G4 (London et al., 2008;Wu et al., 2008)
that form by Hoogsteen hydrogen bonding (Figure 3). For both
triplexes and G4s, FANCJ requires a 5′ single-stranded DNA
tail, consistent with its 5′–3′ directionality of translocation. For
unwinding triplexes this 5′ tailmust reside on thepyrimidinemotif
third strand that invades the major groove of the underlying DNA
double helix. FANCJ has the capacity to resolve intermolecular
(two-stranded or four-stranded) as well as unimolecular G4 sub-
strates (Bharti et al., 2013), which is likely important to suppress
replication-associated G4 substrates and in turn DSB formations
(discussed below).
Aside from unwinding DNA, FANCJ has the ability to harness
the energy from ATP hydrolysis to disrupt protein–DNA interac-
tions. Attesting to its robust capacity, FANCJ was shown to disrupt
the high afﬁnity interaction of biotin bound to a biotinylated
oligonucleotide in an ATP-dependent manner (Sommers et al.,
2009). Of greater biological relevance, FANCJ can destabilize a
RAD51-single-stranded DNA ﬁlament (Figure 4A), and therefore
inhibit DNA strand exchange activity of RAD51 (Sommers et al.,
2009). Thus, FANCJmay limit promiscuous recombination. Alter-
natively, by removing RAD51 from the 3′ invading strand of the
nucleoprotein ﬁlament, FANCJ could enable loading of the DNA
polymerase and promotes DNA synthesis.
FANCJ helicase and translocase activities are also modu-
lated by protein interactions. In particular, FANCJ is blocked
from unwinding partial duplex DNA substrates bound by dou-
ble stranded DNA-interacting proteins (e.g., catalytically inactive
restriction endonuclease, or the telomere binding proteins TRF1,
TRF2). However, this inhibition is overcome by the presence of
RPA in the FANCJ reaction mixtures under conditions that RPA
alone had little effect (Sommers et al., 2014; Figure 4B). The abil-
ity of RPA to stimulate FANCJ displacement of TRF1 or TRF2
from forked duplex substrates harboring telomeric repeats may be
important for remodeling chromosome ends during DNA repli-
cation or repair. Indeed, FANCJ was localized to telomeres of
living cells that operate according to the alternative lengthening
of telomere (ALT) pathway (Dejardin and Kingston, 2009). Since
RPA also increases the ability of FANCJ to unwind duplex and G4s
(Wu et al., 2008), RPA–FANCJ interactions may both clear pro-
tein obstacles and resolve alternate DNA structures during cellular
replication to preserve the genome (see below).
Our biochemical studies further suggest that RPA is important
for enabling FANCJ to bypass bulky adducts or helix-distorting
lesions such as thymine glycol, an oxidative base damage that can
be mutagenic or lethal (Wallace, 2002). FANCJ helicase activ-
ity is strongly inhibited by a single thymine glycol in either
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FIGURE 3 | DNA substrate specificity of FANCJ helicase. See text for details.
the translocating or non-translocating strand of a DNA duplex
(Suhasini et al., 2009). However, RPA stimulates FANCJ to efﬁ-
ciently unwind the substrate harboring thymine glycol in the
non-translocating strand, but fails to do so when the thymine
glycol resides in the translocating strand. The demonstrated high
afﬁnity interaction of RPA with single-stranded DNA harbor-
ing a single thymine glycol (Suhasini et al., 2009), together with
the strand-speciﬁc RPA stimulation of FANCJ helicase activity
on the DNA substrate harboring the thymine glycol, suggest a
model in which RPA promotes strand displacement. Speciﬁcally,
the exposed thymine glycol in the non-translocating strand of
the partially unwound DNA substrate is readily bound by RPA,
resulting in RPA coating of the strand displaced by FANCJ, stabi-
lized duplex separation, and further FANCJ helicase progression
past the thymine glycol leading to complete separation of the
complementary strands. Such a mechanism may be important
for the role of FANCJ to insure timely progression through S
phase (Kumaraswamy and Shiekhattar, 2007), or in an envi-
ronment of heightened oxidative stress. Given the emerging
evidence that the FA pathway suppresses DNA damage induced
by products of normal cellular metabolism such as aldehydes
(Nalepa and Clapp, 2014), it will be of interest to assess how
such aldehyde-induced lesions affect FANCJ and its role in DNA
repair.
POST-TRANSLATIONAL MODIFICATIONS OF FANCJ
There has been considerable interest in the effect of post-
translational modiﬁcations on the functions of DNA repair
proteins and checkpoint signaling, both important components
of the DNA damage response. Post-translational modiﬁcations
of DNA damage response proteins can affect their subcellular
localization, chromatin association, DNA and protein interac-
tions, stability, and catalytic activity. Phosphorylation of FANCJ
mediates interactions promoting repair and checkpoint responses.
The ﬁrst identiﬁed was the phosphorylation of Ser-990, which
is essential for FANCJ binding to the tandem C-terminal BRCT
motifs of BRCA1 (Yu et al., 2003; Figure 2). The interface between
FANCJ and the interacting BRCA1 BRCT repeats was further
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FIGURE 4 | FANCJ uses its motor ATPase to displace proteins bound
to DNA. (A) FANCJ catalytically displaces the major DNA recombinase
protein RAD51. See reference Sommers et al. (2009) and text for details.
(B) Replication protein A (RPA) stimulates FANCJ to eject the shelterin
protein TRF1 (or TRF2) bound to telomeric repeat duplex DNA. See
reference Sommers et al. (2014) and text for details.
deﬁned in structural studies (Yu et al., 2003; Botuyan et al., 2004;
Shiozaki et al., 2004). Loss of this Ser-990 phosphorylation limits
HR, but also enhances polymerase η dependent bypass suggest-
ing that BRCA1 binding to FANCJ is important for directing the
mechanism of DNA damage repair (Xie et al., 2010). Interest-
ingly, the region of FANCJ that binds to the Bloom’s syndrome
protein (BLM) overlaps with the FANCJ Ser-990 phosphoryla-
tion site (Suhasini et al., 2011; Figure 2), raising the possibility
that the protein interaction of FANCJ with BLM is affected by
phosphoSer-990. More recently, a second FANCJ phosphoryla-
tion dependent interaction was identiﬁed at Thr-1133 (Figure 2).
Phosphorylated FANCJ Thr-1133 interacts with the BRCT repeats
of Topoisomerase IIb binding protein 1 (TopBP1) to promote an
ATR-dependent checkpoint in response to replication stress (Gong
et al., 2010).
Acetylation of FANCJ at lysine 1249, the last C-terminal
amino acid (Figure 2), affects the DNA damage response
similar to Ser-990 phosphorylation. When acetylation is pre-
vented, cellular ICL resistance is achieved by a reduced need
for Rad54-mediated HR repair and enhanced dependence on
the translesion polymerase η. This modulation of repair path-
way mechanism could stem from the role of FANCJ and its
acetylation upregulating DNA end resection required for HR.
Dynamic acetylation of FANCJ was also found to maintain
checkpoint signaling following DNA damage (Xie et al., 2012).
Continued studies of post-translational modiﬁcations on FANCJ
and its partners are warranted. For example, it will be impor-
tant to determine if a post-translational modiﬁcation of FANCJ
or the Bloom’s syndrome helicase (BLM) inﬂuences the inter-
action between the two DNA helicases (Figure 2), especially
because FANCJ status dramatically inﬂuences BLM protein sta-
bility by a proteasomal degradation pathway (Suhasini et al.,
2011). It remains to be seen if the phosphorylation or acety-
lation state of FANCJ affects its catalytic activity on a speciﬁc
DNA substrate. On a forked duplex DNA substrate, acetylation
at 1249 did not inﬂuence its activity (Xie et al., 2012). Alterna-
tively, post-translational modiﬁcation of FANCJ may inﬂuence
its subcellular localization. Recently it was reported that ICL
induces localization of FANCJ to the centrosome and FANCJ
is involved in regulation of centrosome biogenesis (Zou et al.,
2013).
NOVEL INSIGHTS TO FANCJ STRUCTURE-FUNCTION
RELATIONSHIPS BY CHARACTERIZATION OF SITE-DIRECTED
MUTANTS
Characterization of helicasemissensemutantsmay be informative
for dissecting the molecular basis of disease, or potential domi-
nant negative effects of debilitating missense mutations (Suhasini
and Brosh, 2013). For FANCJ, the clinical spectrum of mutations
includes missense mutations genetically linked to FA and/or can-
cer. This is not the general case for a number of disease-causing
helicase mutations. For example, only recently were several WRN
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missense mutations genetically linked to the premature aging dis-
order Werner syndrome identiﬁed and found to be in conserved
catalytic domains of the WRN protein (Friedrich et al., 2010).
The vast majority of WRN mutations are limited to frameshift
or nonsense codons resulting in truncated proteins.
The ﬁrst FANCJ mutants to be studied were missense vari-
ants (P47A, M299I; Figure 2) identiﬁed in individuals with
early breast cancer and normal genotypes for BRCA1 or BRCA2
(Cantor et al., 2001). Tumors of the individuals who carried these
twogermline FANCJmutations also carried a copyof thewild-type
(WT) allele, suggesting that loss of functionmay have contributed
to the penetrance of the mutant allele by a dominant negative
mechanism. Biochemical analysis of the corresponding puriﬁed
recombinant FANCJ proteins demonstrated that both missense
mutations (P47A, M299I; Figure 2) affected catalytic activity in a
distinct manner. The P47A substitution in the highly conserved
Walker A box (motif I) inactivated the ATPase and helicase func-
tions of FANCJ, whereas the M299I mutation located in the Fe-S
cluster upregulated its ATPase activity (Cantor et al., 2004). A sub-
sequent study demonstrated that the FANCJ-M299I protein could
harness its elevated ATP hydrolysis to unwind a DNA substrate
with damage in its sugar phosphate backbone in a more proﬁcient
manner (Gupta et al., 2006). Based on these studies, it was pro-
posed that perturbation of FANCJ catalytic activity interferes with
the helicase’s normal role in the DNA damage response leading to
tumorigenesis; however, a better understanding of FANCJ’s pre-
cise role in cellular transformation is required. As discussed below,
expression of certain FANCJ mutant proteins in a normal FANCJ
background confer sensitivity to DNA damaging agents, suggest-
ing that a singlemutant FANCJ allele could be pathogenic. Further
characterization of FANCJ variants using cell- and animal-based
models may be helpful.
Analysis of the FA-associated FANCJ-A349P mutant provided
insight to the pathogenesis of FA and the role of the Fe-S domain
(Wu et al., 2010; Figure 2). The alanine to proline substitution is
adjacent to one of the highly conserved cysteine residues impor-
tant for chelation of Fe atoms. Inheritance of the A349P mutation
and a second mutation encoding a prematurely truncated FANCJ
protein resulted in intrauterine growth failure and death as a still-
born fetus with a gestational age of 22 weeks (Levran et al., 2005).
Our genetic analysis demonstrated that expression of the FANCJ-
A349P mutant allele in FANCJ-null FA-J patient cells failed to
rescue sensitivity to the DNA cross-linking agent MMC; simi-
larly, expression of FANCJ-A349P in fancj null chicken DT40 cells
failed to rescue cisplatin sensitivity (Wu et al., 2010). Moreover,
expression of the FANCJ-A349P mutant in FA-J cells or fancj
null chicken cells failed to restore resistance to the G4 ligand
telomestatin (TMS). These studies suggested that the FANCJ-
A349P mutant is defective for ICL processing and G4 unwinding
in vivo. Moreover, expression of FANCJ-A349P in cells express-
ing the normal FANCJ protein exerted a dominant negative effect,
presenting the possibility that a single mutant FANCJ allele could
be pathogenic. In vitro analysis revealed that the A349P substitu-
tion interfered with the functionality of the FANCJ Fe–S cluster
and uncoupled ATP-dependent DNA translocation from helicase
activity on duplex or G4 DNA substrates (Wu et al., 2010). Thus,
an intact Fe–S domain is critical for FANCJ DNA unwinding and
this activity is fundamentally important for FANCJ ICL repair
and G4 DNA metabolism (Wu et al., 2010). It remains to be
determined if the functions of FANCJ in ICL repair and G4
unwinding are linked or if separation-of-function mutants exist.
Ongoing efforts in this area could elucidate the importance of
FANCJ in the FA pathway of cross-link repair versus functions
outside the FA pathway that may also be signiﬁcant for genome
stability.
FANCJ also has a conservedQmotif (also calledmotif 0) found
in both RNA and DNA helicases that is predicted to coordinate
ATP binding and hydrolysis to catalytic DNA strand separation
(Tanner et al., 2003; Figure 2). Biophysical analysis of the puri-
ﬁed recombinant FANCJ-Q25A mutant protein disrupted in the
Q motif revealed that its assembly state was dramatically altered
compared to the recombinant WT FANCJ protein. FANCJ-Q25A
protein was only a monomer, whereas FANCJ-WT protein was
nearly equally monomer and dimer (Wu et al., 2012). Thus, the Q
motif in FANCJ plays a critical role in multimerization. FANCJ-
Q25Awas defective for DNAbinding,ATP hydrolysis, and helicase
activity. Consistent with the biochemical results, expression of
the FANCJ-Q25A mutant protein in fancj null cells failed to res-
cue their sensitivity to a DNA cross-linking agent or G4 ligand.
Moreover, expression of the FANCJ-Q25A mutant allele in a
WT FANCJ background resulted in dominant negative pheno-
types for ICL or G4 ligand resistance. Co-immunoprecipitation
experiments with nuclear extracts demonstrated that the FANCJ-
Q25A mutant protein retained its ability to interact with known
protein partners of FANCJ (TopBP1, BRCA1), suggesting that
these retained interactions could contribute to the dominant
negative nature of the mutant allele; however, further stud-
ies are required to ascertain the precise mechanism. From a
clinical perspective, it is of signiﬁcance that the FANCJ-Q25A
mutant is similar to a patient-derived BLM missense muta-
tion in the Q motif (Q672R) that impairs BLM foci formation
after cellular exposure to agents that impose replication stress
(Ellis et al., 1995; Wu et al., 2012). Therefore, dimer formation
may be essential for FANCJ focal accumulation and function
in vivo.
Two FApatient-derivedmissensemutations inmotif Ia, R251C,
and Q255H, were characterized by the Wu lab (Guo et al., 2014;
Figure 2). Although expression of either R251C or Q255Hmutant
could not rescue the cisplatin sensitivity of a fancj null cell line,
the two mutations exerted markedly different effects on the bio-
chemical functions of FANCJ in vitro. Both FANCJ motif Ia
mutants abolished DNA helicase activity. The R251C mutation
strongly interfered with FANCJ DNA binding and consequently
its DNA-dependent ATPase activity. Instead, the Q255H mutant
displayed elevated FANCJ DNA binding, a normal ATPase func-
tion, and ability to translocate on single-stranded DNA. In this
regard, the Q255Hmutant behaved similarly to the FANCJ-A349P
mutant which was also able to translocate on single-stranded
DNA in an ATP-dependent manner but failed to unwind even
short 20 bp duplex substrates (Wu et al., 2010). For either the
Q255H or R251C mutant, the ability to translocate on single-
stranded DNA did not translate into efﬁcient disruption of
protein-DNA complexes. Collectively, these studies suggest that
FANCJ translocase activity without protein complex disruption
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and/or DNA unwinding is insufﬁcient for its in vivo function.
Nevertheless, the dominant negative phenotype exerted by FANCJ
mutant alleles (A349P, Q25A, R251C, and Q255H) that impair
DNA helicase (but not necessarily ATPase activity) demonstrate
that catalytic DNA unwinding is vital for FANCJ function and
suggests that FANCJ heterozygosity may contribute to tumori-
genicity or disease-associated phenotypes. For a further discussion
of helicase-inactivatingmutations as a basis for dominant negative
phenotypes, see (Wu and Brosh, 2010b).
Evidence continues to build that FANCJ and other players in
the FA pathway are bona ﬁde tumor suppressor genes, even out-
side their roles in the FA pathway (Pickering et al., 2013; Park
et al., 2014; Pauty et al., 2014). For example, whole genome-
sequencing of Icelanders led researchers to discover frameshift
mutations in the BRIP1 (FANCJ) gene that vastly elevate the
risk of invasive ovarian cancer (Rafnar et al., 2011). More-
over, a BRIP1 frameshift mutation was associated with a 36%
increased risk of cancer in general and a reduced lifespan of
3.6 years compared to non-carriers (Rafnar et al., 2011). This
work and that of others, reviewed in (Cantor and Guillemette,
2011), emphasizes the prominent role of FANCJ as a tumor
suppressor, which may be informative for future studies in per-
sonalized medicine that exploit the mutational status of FANCJ
and other DNA repair helicases (see below). The spectrum
of associated cancers could be broad. Indeed, we found a
number of protein coding mutations in FANCJ in melanoma
genomes (one allele), suggesting that FANCJ deﬁciency may
be a risk factor for skin cancer and possibly associated tumors
could be sensitive to ICL-inducing agents (Guillemette et al.,
2014).
FANCJ AND ITS PROTEIN PARTNERS ARE RECRUITED TO
DNA DAMAGE FOCI IN A REGULATED AND LESION-SPECIFIC
MANNER
Given the direct interaction of FANCJ with BRCA1, the depen-
dency of these proteins on each other for localization at lesions
has been examined. Indeed, these proteins colocalize at sites of
DNA damage foci following HU, IR, and at laser-induced stripes
(Cantor et al., 2001; Greenberg et al., 2006). BRCA1 mutant cells
display reduced immunoﬂuorescent focal staining for FANCJ in
untreated cells as well as cells exposed to DNA damaging agents
(Cantor et al., 2001; Gupta et al., 2007). However, the contribution
of FANCJ to BRCA1 localization toDNAdamage sitesmay be time
or context dependent. FANCJ status did not affect recruitment of
BRCA1 to laser-induced DSBs or psoralen (Pso)-ICLs (Suhasini
et al., 2013). However, the number and intensity of BRCA1 foci
in FANCJ-deﬁcient cells exposed to IR was reduced at time points
as early as 1 h post irradiation (Peng et al., 2006). Thus, there
may be separate pools of FANCJ and BRCA1 or a sub-fraction
of FANCJ may contribute to BRCA1 recruitment or retention at
foci after IR exposure. Controlling the localization of BRCA1 to
sites of DNA damage would directly affect its DNA repair func-
tion, andhave potential consequences for cellular homeostasis. For
example, oncogenic RAS transformation down-regulates FANCJ
expression, which causes BRCA1 dissociation from chromatin,
resulting in an impaired DNA damage response leading to cellular
senescence (Tu et al., 2011).
FIGURE 5 | Spatio-temporal recruitment of FANCJ and its protein
partners to site of DNA damage. Confocal microscopy studies with living
cells were used to elucidate the requirements of FANCJ or its interacting
DNA repair factors to laser-induced psoralen (Pso)-interstrand cross-links
(A,C) or laser-induced double strand breaks (DSB; B,D). See reference
Suhasini et al. (2013) and text for details.
It is also important to note that otherDNA repair proteins func-
tionwith or in parallel with BRCA1 localize FANCJ to sites of DNA
breaks. In particular, theDSB repair proteinMRE11 and its associ-
ated nuclease activity is necessary for efﬁcient FANCJ recruitment
to laser-induced DSBs (Suhasini et al., 2013; Figure 5A). Consis-
tent with this observation, CtIP is also delayed in its recruitment
to DSBs in cells that are deﬁcient in MRE11 exonuclease, that
have reduced FANCJ recruitment to DSBs (Suhasini et al., 2013).
Recent work from the Paull laboratory has implicated a catalytic
role of CtIP in 5′ strand resection that is involved in the removal of
DNA adducts at DNA breaks (Makharashvili et al., 2014). Perhaps
FANCJ collaborates with CtIP to remove secondary structures
therefore enabling CtIP to efﬁciently incise and process DNA ends,
such as at common fragile sites (Wang et al., 2014). It is plau-
sible that FANCJ’s role in end resection may be independent of
BRCA1, similar to what was determined for CtIP (Polato et al.,
2014).
A critical protein partner that FANCJ collaborates with is
RPA (Gupta et al., 2007). FANCJ and RPA robustly co-localize
after DNA damage induced by IR or MMC or replication stress
imposed by hydroxyurea (HU), which depletes nucleotide pools.
RPA foci formation was not dependent on FANCJ mutational sta-
tus after MMC treatment or IR exposure (Gupta et al., 2007),
suggesting that FANCJ helicase activity is not a prerequisite for
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creating single-stranded DNA at DNA breaks that RPA nucle-
ates on. However, RPA foci are reduced in FANCJ-deﬁcient cells
exposed to HU for a short time period (20 min; Gong et al.,
2010) or ultraviolet (UV) light (Guillemette et al., 2014), sug-
gesting FANCJ helicase activity provides single-stranded DNA
loading zones for RPA when the replication fork is stalled. RPA
binds to FANCJ and stimulates its helicase (Gupta et al., 2007)
and DNA-protein displacement activities (Sommers et al., 2014),
as mentioned above. Based on these observations, we favor the
hypothesis that FANCJ together with RPA binds a key DSB repair
intermediate or stalled replication fork structure and RPA stim-
ulates FANCJ’s helicase and/or protein displacement activity to
allow appropriate and efﬁcient processing during the maturation
of the DNA intermediate.
FANCJ also binds directly to the mismatch repair (MMR)
protein MLH1 (Peng et al., 2007). While MLH1 binding did
not demonstrate any notable changes in FANCJ helicase activ-
ity in vitro, MLH1 is critical for FANCJ localization to sites of
DNA crosslinks. In particular, using a laser confocal microscopy
approach with living cells, we examined the recruitment of FANCJ
to laser-activated Pso-ICLs (Suhasini et al., 2013). This analy-
sis demonstrated that FANCJ relies on MLH1 and a member
of the FA core complex, FANCA, to recruit efﬁciently to the
laser-activated Pso-ICL (Figure 5B). FANCJ localization to UV
light induced DNA crosslinks also requires the MLH1 interac-
tion as well as the upstream MMR protein MSH2 (Guillemette
et al., 2014). This is logical given that the physical interaction
between FANCJ and MLH1 is required for cells to properly
respond to agents that induce ICL damage or UV damage (Peng
et al., 2007; Guillemette et al., 2014). Localization of FANCJ by
MMR proteins may in turn limit deleterious MMR functions
at a stalled fork. This idea is based on the fact that defects
in cells lacking the FANCJ-MLH1 interaction are suppressed by
depletion of MSH2 (Peng et al., 2014). Coordination by FANCA
and MMR proteins could ensure that FANCJ helicase function
is set to unwind DNA or displace proteins to restore replica-
tion fork progression following ICLs or other replication blocking
agents.
The relationship of FANCJ with FANCD2 is more complex.
While FANCJ operates downstream of FANCD2 monoubiqui-
tination (Litman et al., 2005; Figure 1), FANCD2 recruitment
to Pso-ICLs, not but laser-induced DSBs, was dependent on
FANCJ (Suhasini et al., 2013; Figure 5C). Consistent with these
observations, FANCJ is recruited to Pso-ICLs much earlier than
FANCD2. These ﬁndings correlate with those of the Andreassen
lab that reported that FANCJ foci formed normally in FANCD2-
deﬁcient cells after exposure to theDNAcross-linkerMMC(Zhang
et al., 2010). In more recent studies, the Kupfer lab reported
that FANCD2 is required for proper chromatin localization of
FANCJ, suggesting a mechanism whereby FANCD2 helps to regu-
late FANCJ’s role in downstream events of the FA pathway (Chen
et al., 2014). In addition, they propose a model in which FANCJ
sequesters non-monoubiquitinated FANCD2 from chromatin in
the absence of DNA damage; therefore, a collaborative interaction
between FANCJ and FANCD2 could exist that is necessary for the
appropriate DNA damage-induced chromatin association of the
two FA proteins.
FANCJ also binds and serves to localize the BLM helicase to
DSBs (Suhasini et al., 2013; Figure 5D). The precise role of FANCJ
in BLM recruitment to laser-induced DSBs or its function at DNA
ends is being investigated, and a potential partnership between
FANCJ and BLM in processive strand resection is a possibility
(Suhasini and Brosh, 2012). Based on biochemical evidence that
FANCJ and BLM helicases synergistically unwind damaged DNA
(Suhasini et al., 2011), we proposed a model that the two helicases
with opposite directionalities of translocation move together in a
complex as part of the end resectionmachinery involving RPA and
the 5′ structure-speciﬁc nucleases DNA2 or EXO-1 to catalytically
resect single-strandedDNA to provide the 3′ single-stranded over-
hang for strand invasion step of HR repair (Suhasini and Brosh,
2012). Our recent work showing that FANCJ or a human RecQ
helicase (RECQ1) can efﬁciently dislodge protein bound to duplex
DNA in a RPA-dependent manner (Sommers et al., 2014) poses a
scenario in which FANCJ and BLM with their interacting part-
ner RPA displace proteins bound near double-stranded ends and
resolve secondary structure or damaged DNA to enable processive
and kinetically efﬁcient end resection.
Clearly a concerted hierarchy exists for FANCJ and its interact-
ing partners to be recruited toDNAdamage sites and subsequently
act. Further studies are needed because they may provide insights
to DNA repair pathway cascades or the cross-talk between DNA
damage response regimes. For example, the interaction of FANCJ
with the MRN complex and BLM helicase suggests that FANCJ
may have both early and late roles in DSB repair. FANCJ has
the ability to inhibit MRE11 3′–5′ exonuclease activity (Suhasini
et al., 2013), which may serve to harness initial end trimming
by MRE11 to avoid excessive end resection that would gener-
ate 5′ single-stranded tailed duplex. Secondly FANCJ with RPA
may facilitate processive strand resection by its interaction with
the BLM-DNA2 or BLM-EXO-1 complexes to yield the 3′ single-
stranded tailed duplex. Biochemical reconstitution experiments
with puriﬁed proteins and deﬁnedDNA substrates, as well as care-
fully designed cell-based assays should address the efﬁcacy of these
models.
To ensure a robust DNA damage response and coordinate
repair processing, it appears that more than one pathway con-
tributes to the localization of FANCJ. As illustrated above, FANCJ
recruitment to ICLs or DSBs is determined by proteins that either
interact directly with FANCJ or operate in the same pathway.
Indeed, both nucleotide excision repair (NER) andMMR proteins
promote the localization of the FANCJ to sites of UV-induced
lesions (Guillemette et al., 2014; Figure 6). MMR proteins ini-
tially recruit FANCJ.However, the further accumulation of FANCJ
requires dual incision by the NER endonucleases XPF and XPG
(Guillemette et al., 2014). Conceivably, the NER-dependent inci-
sion provides an ideal substrate for FANCJ at the lesion site.
The combined MMR and NER localization of FANCJ ensures
an S-phase checkpoint, lesion repair, and the suppression of UV-
inducedmutations. Supporting that multiple pathways contribute
to high ﬁdelity repair after UV irradiation, similar to skin tumors
fromXP patients (Dumaz et al., 1993),MMR-deﬁcient (Borgdorff
et al., 2006) and FANCJ-deﬁcient (Guillemette et al., 2014) cells
display an elevated frequency of UV-induced C > T point muta-
tions. Moreover, along with NER genes, FANCJ and MMR genes
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FIGURE 6 | Localization of FANCJ to UV-induced DNA damage. FANCJ
recruitment to UV-induced DNA damage is dependent on the mismatch
repair factors MLH1 and MSH2, and NER factors XPF and XPG. See
reference Guillemette et al. (2014) and text for details.
are mutated in melanoma (Guillemette et al., 2014). The NER and
FA-associated XPF protein promotes RPA phosphorylation in S-
phase cells (Bomgarden et al., 2006). Given that XPF promotes
FANCJ accumulation in S-phase cells, it follows that FANCJ also
functions to promote RPA phosphorylation throughout S-phase.
This function could be shared by FANCJ partners, such as BLM or
the FA pathway, explaining its link to the UV response and check-
points that limit genomic instability (Suhasini et al., 2011; Kelsall
et al., 2012; Nalepa et al., 2013; Singh et al., 2013).
ROLE OF FANCJ AND THE FA PATHWAY IN THE BROADER
CONTEXT BEYOND DNA REPAIR
Much emphasis has been placed on the impact of ICLs on actively
dividing cells and role of the FA pathway in repairing such lesions
encountered by the replication for. ICLs may arise naturally or
be induced exogenously by chemicals used in chemotherapy. It is
important to note that ICLs may have detrimental effects in non-
dividing cells, given that they would interfere with other processes
such as transcription. This has become a topic of increased interest,
particularly because the processes of DNA repair and transcrip-
tion are both highly important and inter-related. Human diseases
with inherited defects in classic DNA repair genes (e.g., nucleotide
excision repair) often display transcriptional deﬁciencies which
are likely to culminate in pleiotropic symptoms including devel-
opmental abnormalities and features of premature aging [for
review, see (Kamileri et al., 2012a)]. For example, the XPF-ERCC1
nuclease responsible for ICL unhooking in the FA pathway is
recruited to active promoters and implicated in chromatin mod-
iﬁcations that inﬂuence transcriptional activation (Le May et al.,
2010; Kamileri et al., 2012b). Alterations to chromatin packaging
due to mutations in DNA repair genes are suspected to underlie
the phenotypic defects that contribute to developmental disor-
ders that extend beyond DNA repair andmaintenance of genomic
stability. The connection of ICL accumulation to perturbed tran-
scriptional regulation in an ERCC1- defective model of a human
progeroid syndrome characterized by loss of fat tissue suggests
how DNA damage can inﬂict detrimental effects in non-dividing
cells (Karakasilioti et al., 2013). Defects in the FA pathway fall into
this class of diseases as the clinical symptoms include not only can-
cer and hematologic abnormalities but often a range of congenital
issues that can include skeletal defects and short stature, as well as
renal dysfunction, abnormal pigmentation, and osteoporosis (Kee
and D’Andrea, 2012). As mentioned above, FANCD2 is proposed
to control FANCJ’s localization to chromatin and its involvement
indownstreamevents of the FApathway (Chen et al., 2014). There-
fore, it is of great importance to ascertain the probable dependent
and independent roles of FANCJ and the FA pathway in transcrip-
tional regulation. In terms of FANCJ, a leading hypothesis builds
from its role as a G4 resolving enzyme that may target predicted
G-quadruplexes (G4s) found near promoter elements believed to
regulate transcription initiation (see below).
INVOLVEMENT OF FANCJ DURING REPLICATION STRESS
Replication stress can be a source of genomic instability. Cellular
data have implicated FANCJ in helping to cope with replication
stress induced exogenously by chemical exposure. Human cells
mutated in FANCJ or acutely depleted of FANCJ by RNA inter-
ference are sensitive to DNA cross-linking agents that block fork
progression (Bridge et al., 2005; Litman et al., 2005; Peng et al.,
2007), or HU that causes fork stalling (Suhasini et al., 2011).
Even in the absence of agents that exogenously induce replication,
a role for FANCJ helicase activity to insure timely progression
through S phase has been demonstrated (Kumaraswamy and
Shiekhattar, 2007). FANCJ is implicated in intra-S phase check-
point signaling through its interaction with TopBP1, which allows
for activation of ataxia telangiectasia and Rad3-related (ATR), a
requirement for checkpoint kinase 1 (CHK1; Gong et al., 2010).
However, it is still unclear what the function(s) of FANCJ may
be to inﬂuence events associated with fork stalling. When the
replisome encounters a replication-blocking lesion or stalls due
to replication stress induced by a small molecule that impedes the
replicative helicase or depletes the nucleotide pool, the nascent
leading and lagging strands can anneal to each other to form a
Holliday Junction-like chicken foot DNA structure [for review,
see (Atkinson and McGlynn, 2009)]. This process is known as
fork regression or fork reversal, and provides a mechanism for
repair machinery to gain access to the lesion as well as stabi-
lize the fork. Whereas certain RecQ helicases (e.g., WRN, BLM;
Machwe et al., 2006; Ralf et al., 2006) were shown to support
fork regression, FANCJ is not directly implicated in this pro-
cess. However, as a 5′–3′ DNA helicase, FANCJ may collaborate
with a 3′–5′ helicase (e.g., WRN, BLM) to promote fork regres-
sion. Given that FANCJ has already been demonstrated to interact
with BLM (Suhasini et al., 2011), the FANCJ–BLM partnership
may contribute to concerted fork regression by opposite polarity
helicases.
Aside from its proposed role in DNA end processing to ini-
tiate HR repair (previous section), FANCJ may help to process
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DNA structures associated with stalled replication forks or reg-
ulate such processing events. The interaction between FANCJ
and MLH1 appears to be critical for cells to recover from repli-
cation stress induced by ICLs or the DNA polymerase inhibitor,
aphidicolin. As mentioned above, deletion of MSH2 suppresses
replication restart defects in cells lacking the FANCJ–MLH1 inter-
action (Peng et al., 2014). Thus, to restart stalled replication forks,
FANCJ through itsMLH1 interaction could normally unwind and
eliminateDNA structures boundbyMSH2or displaceMSH2 from
such structures. Mre11 has been implicated in the restart of stalled
replication forks (Bryant et al., 2009; Hashimoto et al., 2010). As
proposed for the tumor suppressor and HR factor BRCA2 as
well as the DNA damage sensor poly (ADP-ribose) polymerase
1 (PARP1; Schlacher et al., 2011; Ying et al., 2012), FANCJ may
help to prevent uncontrolled MRE11-dependent degradation of
stalled replication forks by inhibiting its nuclease activity. Such an
anti-nuclease role may aid in fork stabilization without excessive
single-strandedDNAproduction to allow for regulated checkpoint
signal transduction and effective repair of the replication-blocking
lesion.
FANCJ RESOLVES G-QUADRUPLEX DNA TO ENABLE
SMOOTH REPLICATION AND PRESERVE GENOMIC
INTEGRITY
G-quadruplexes, composed of planar stacks of four guanine
residues engaged in Hoogsteen hydrogen bonding, are now
believed to form in vivo and exert biological effects on DNA
replication and transcription, and play unique structural roles in
telomere capping (Wu and Brosh, 2010a; Bochman et al., 2012;
Maizels and Gray, 2013). FANCJ, and certain other DNA helicases
(e.g., PIF1,WRN, BLM), resolve G4 DNA structures in vitro; how-
ever, the biological signiﬁcance of G4 resolution by the various
human DNA helicases in vivo is less clear. Human cells deﬁ-
cient in FANCJ, but not FANCA or FANCD2, were found to be
sensitive to the G4 binding drug TMS, suggesting a role of the heli-
case to preserve genomic stability at G4-forming sequences that
is independent of the classic FA DNA repair pathway (Wu et al.,
2008); furthermore, a FA-J human patient cell line was found to
accumulate deletions at predicted G4-forming sequences in the
genome (London et al., 2008). Although a number of DNA heli-
cases have been shown to unwind intermolecular G4 structures,
FANCJ is distinct among the Fe-S cluster helicases tested in its abil-
ity to resolve entropically favored intramolecular G4 substrates
(Bharti et al., 2013). Consistent with the biochemical results, a
deﬁciency in FANCJ, but not the Fe–S helicases DDX11 or XPD,
sensitized human cells to TMS as measured by induction of the
DNA damage marker γ-H2AX (Bharti et al., 2013). These ﬁnd-
ings suggest that FANCJ has a specialized function among the
Fe–S helicases to facilitate smooth replication of genomic regions
prone to form G4s in order to prevent fork breakage (Figure 7).
A recent study using Xenopus egg extract and single-stranded
plasmid DNA template with a predicted G4-forming sequence
validated the role of FANCJ to promote DNA synthesis through
G4 structures (Castillo et al., 2014). It will be of interest to deter-
mine if a putative role of FANCJ at telomeres involves its ability to
resolve the G-rich telomeric tail and inﬂuence telomere capping
events.
FIGURE 7 | FANCJ resolves G-quadruplex DNA to maintain genomic
stability and cellular homeostasis. See text for details.
Recent advances using the chicken DT40 cell lines have
improved our understanding of the role of FANCJ in DNA repair
and G4 DNA metabolism. Human FANCJ can rescue the sensi-
tivity of chicken brip1/fancj mutant cells to agents that induce
DNA cross-links (Bridge et al., 2005) or stabilize G4 structures
(Wu et al., 2008), indicating a conservation of function in the ver-
tebrate species. In addition to its role in protecting brip1 cells from
G4-associated genomic instability, the chicken ortholog of FANCJ
serves a more general protective role in chromosomal mainte-
nance that appears to operate outside the FA pathway (Kitao et al.,
2011; Figure 7). In subsequent work, it was shown that FANCJ,
together with the RecQ helicases WRN and BLM, preserve epi-
genetic stability by helping to efﬁciently couple histone recycling
with replication fork progression through their ability to resolve
G4s that impede smooth DNA synthesis (Sarkies et al., 2012).
FANCJ seems to be a central player in the maintenance of epi-
genetic stability by collaborating as well with the REV1 translesion
polymerase at G-rich sequences predicted to form quadruplexes.
The precise molecular mechanisms of how these processes occur
are still not well understood, but the model proposed by the Sale
group predicts that FANCJ with its opposite polarity of directional
movement may initiate its action on the opposite side of G4 struc-
ture(s) as that of the 3′–5′ RecQ heli or the TLS polymerase REV1
(Sarkies et al., 2012).
To examine the role of FANCJ in cellular DNA replication, the
Niedzwiedz lab employed a DNA ﬁber analysis in isogenic fancj
null and WT DT40 cells and determined that FANCJ helps to
promote replication fork progression at regions prone to stalling,
such as G4-forming sequences (Schwab et al., 2013). Furthermore,
stabilization of G4 structures in FANCJ-deﬁcient cells by the G4
binder TMS quenched fork progression, resulting in uncoupling
of leading and lagging strand synthesis. The ability of FANCJ to
enable smooth replication fork progression would help to main-
tain normal chromatin structure by preventing its condensation
and reorganization.
FANCJ-deﬁcient DT40 cells exposed to the G4 ligand TMS
displayed stronger staining by a murine monoclonal antibody
speciﬁc for binding G4 DNA compared to untreated fancj null
cells, or normal cells exposed to TMS (Henderson et al., 2013).
Enrichment of G4 DNA in FANCJ-deﬁcient cells exposed to TMS
Frontiers in Genetics | Genetics of Aging October 2014 | Volume 5 | Article 372 | 10
Brosh and Cantor Functional roles of FANCJ helicase
provided the ﬁrst evidence that genetic and environmental con-
ditions can synergize in the accumulation of G4 DNA in vivo.
The emerging evidence for a role of FANCJ in replication of G4
motifs in avian cells supports the hypothesis for a conserved role
of FANCJ in humans. Nonetheless, there are likely additional
functions of FANCJ G4 resolving activity in vivo, including the
control of gene expression (Figure 7); however, this hypothesis
remains to be formally tested in human cells. It is well known
that G-rich sequences predicted to form G4 are enriched in pro-
moter regions especially at transcriptional start sites (Huppert
and Balasubramanian, 2007), and a correlation exists between the
presence of predicted G4 and promoter-proximal transcriptional
pausing (Eddy et al., 2011). Although a deﬁnitive role of G4 res-
olution by FANCJ to control gene expression has not yet been
elucidated, other DNA helicases including XPB, XPD (Gray et al.,
2014), BLM (Nguyen et al., 2014), and RECQ1 (Li et al., 2014)
bind G4 structures and regulate expression of genes characterized
by the presence of G4 DNA motifs. It is unclear if differential
roles in transcriptional regulation exist for G4 binding versus
resolution by a DNA helicase, given that certain helicases [e.g.,
RECQ1 (Popuri et al., 2008; Wu et al., 2008) and XPB (Gray et al.,
2014)] bind but poorly unwind G4 DNA in vitro; furthermore, it
is yet unclear if human XPD resolves G4 DNA because different
results were obtained from in vitro studies using XPD proteins
from two distinct thermophilic species (Bharti et al., 2013; Gray
et al., 2014). Given the evidence that FANCJ and its homologs
play an important role in G4 metabolism, it seems likely that
FANCJ unwinding of G4s will inﬂuence gene expression of proto-
oncogenes where G4 motifs are prominent (Eddy and Maizels,
2006; Duquette et al., 2007; Brown et al., 2011). Further studies
are needed to establish direct links and meaningful relationships
between disease pathogenesis and regulated expression of mes-
senger RNA and microRNA molecules by FANCJ and other DNA
helicases.
FANCJ AS A POTENTIAL TARGET FOR CLINICAL AND
PHARMACEUTICAL TREATMENT
Our group and others have been keenly interested in the prospect
of helicase-based biomarkers and targeting DNA helicases like
FANCJ to enhance existing or developing therapeutic strategies for
treating cancers (Brosh, 2013). This prospect has been fueled by
observations that the expression of many DNA damage response
genes is up-regulated in rapidly proliferating cells and tumors,
leading to their resistance to chemotherapy drugs or radiationused
to combat cancer. In two recent studies, the inﬂuence of FANCJ
expression on sensitivity of cancer cells or tissues to chemotherapy
drugs was determined. In the ﬁrst, Nakanishi et al. (2012) found
that FANCJ expression in tumor tissues was elevated compared
to normal epithelial tissue, which correlated with resistance to the
chemotherapy drug 5-ﬂuorouracil (5-FU) in tumors with nor-
mal MLH1 expression. Mori et al. (2013) determined that gastric
cancer cells exposed to 5-FU down-regulated FANCJ expression,
leading to their enhanced sensitivity to the ICL-inducing agent
oxaliplatin. Such observations raise the exciting possibility that
FANCJ is differentially expressed in tumors which may serve as
a useful predictive biomarker for designing treatment strategies
tailored to the cancer type.
From a related perspective, the development of small molecules
that target FANCJ for helicase inhibition may provide a means to
achieve synthetic lethalitywith chemotherapy drugs or in a deﬁned
genetic background to kill cancer cells, provided that a therapeu-
tic window is achieved. Our work on the discovery of a WRN
helicase inhibitor provided a proof-of-principle for the helicase-
targeted approach to induce chemical or genetic synthetic lethality
of cancer cells (Aggarwal et al., 2011, 2013a,b). The observation
that a BLM helicase inhibitor can cause elevated sister chromatid
exchange in cultured cells is provocative (Nguyen et al., 2013), and
sets the stage to search for FANCJ inhibitors, given FANCJ’s inter-
action with BLM and the ﬁnding that acute depletion of FANCJ
causes elevated sister chromatid exchange (Suhasini et al., 2011).
On the opposite side of the spectrum, it might also be useful to
conduct smallmolecule screens to identify compounds that restore
the function of a misfolded helicase protein caused by a disease-
linked mutation. Given that a number of missense mutations in
FANCJ are linked to FA or associated with cancer, FANCJ may be
a good candidate protein to target for intervention.
Lastly, the function of FANCJ in G4 DNA metabolism suggests
an avenue to explore. G4 structures which form at telomeres or the
promoters of proto-oncogenes most likely play a prominent role
in the ability of cancer cells to thrive or senesce. Indeed, telomerase
inhibitorswhichprevent the elongationof theG-rich telomere tails
at chromosome ends are in clinical trials (Buseman et al., 2012). If
G4 structures in cancer cells are stabilized by G4 ligands directly or
by blocking telomeric G4 unwinding with small molecules against
G4 resolving helicases such as FANCJ or PIF1, then cancer cells
may be caused to senesce and ultimately targeted for elimination.
It seems probable that further studies will address the efﬁcacy of
targeting FANCJ and other DNA helicases as a possible strategy in
cancer therapy.
SUMMARY
In this review, we have attempted to provide a comprehensive view
of what now appears to bemulti-faceted roles of FANCJ in cellular
DNAmetabolism. Discovered 13 years ago as a BRCA1-interacting
protein, FANCJ helicase is now regarded as a bona ﬁde tumor sup-
pressor and genetically linked to the cancer-prone disorder FA
characterized by progressive bone marrow failure; however, the
precise function(s) of FANCJ in the FA pathway of ICL repair is
still not well understood. In addition, cellular and biochemical
studies have demonstrated an important role of FANCJ to resolve
G4DNA structures that potentially interfere with normal chromo-
some packaging, replication, and transcription. FANCJ interacts
with a number of DNA damage response proteins and appears
to be a key player in maintaining chromosomal stability through
its involvement in DNA repair and checkpoint signaling. With
FANCJ’s emergence as a uniquely important genome caretaker,
future studies may explore FANCJ as a potential target for clinical
and therapeutic strategies. In spite of the tremendous progress,
much still remains to be learned about FANCJ and avenues for
biomedical advances.
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